A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT01582451 · COMPLETED

Trial details

NCT number: NCT01582451
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2012-05-01
Primary completion: 2013-05-01
Enrollment: 466

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.